The network of procedures and facilities involved in the creation, production, delivery, and storage of cellular and gene-based medications is referred to as the "Cell and Gene Supply Chain". The procurement of raw materials, gene or cell manipulation, quality control, shipment, and patient administration are a few of the phases that make up this intricate system. Ensuring the safety and integrity of these novel therapies throughout the whole supply chain is essential to deliver dependable, effective, and uniform care to patients.